Related Experiment Video
Updated: Jul 20, 2026

13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Chapter 14: HPV vaccine introduction in industrialized countries
Thomas C Wright1, Pierre Van Damme, Heinz-Josef Schmitt
1Department of Pathology, Columbia University, 630 W. 168th Street, New York, NY 10032, USA. tcw1@columbia.edu
Vaccine
|September 5, 2006
Summary
Introducing a new vaccine, like the human papillomavirus (HPV) vaccine, requires regulatory approval, expert recommendations, and funding. Successful programs depend on coordinated efforts in vaccine supply, delivery, coverage, and surveillance.
Area of Science:
- Immunology
- Public Health
- Vaccinology
Background:
- Vaccine introduction involves achieving licensure, expert recommendations, and funding.
- Successful vaccination programs require coordinated efforts in supply, delivery, coverage, and surveillance.
- Human papillomavirus (HPV) vaccination presents unique challenges due to knowledge gaps.
Purpose of the Study:
- To outline the essential milestones and programmatic components for successful vaccine introduction.
- To highlight the specific challenges associated with human papillomavirus (HPV) vaccine implementation.
- To identify areas where further knowledge is needed for effective HPV vaccination programs.
Main Methods:
- Review of established vaccine introduction frameworks.
- Analysis of programmatic components critical for vaccination success.
- Identification of knowledge gaps specific to HPV vaccine implementation.
Main Results:
- Vaccine introduction hinges on three initial milestones: licensure, expert recommendations, and funding.
- Successful programs necessitate coordinated management of vaccine supply, service delivery, coverage, surveillance, finance, and political will.
- Significant knowledge gaps impede the optimal implementation of HPV vaccination programs.
Conclusions:
- Achieving successful vaccine programs requires addressing both initial milestones and ongoing programmatic elements.
- The unique characteristics of HPV vaccination necessitate targeted strategies to overcome implementation barriers.
- Further research is crucial to fill knowledge gaps and optimize HPV vaccine impact.
Related Concept Videos
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Overview
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Chickenpox
Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
